PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.770
+0.011 (1.44%)
At close: Jun 26, 2026, 4:00 PM EDT
0.780
+0.010 (1.34%)
After-hours: Jun 26, 2026, 7:49 PM EDT
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,743,213
Market Cap
8.26M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| Bolt Biotherapeutics | 23 |
| AIM ImmunoTech | 21 |
| Imunon | 20 |
| MetaVia | 8 |
| Immuron | 7 |
| Ernexa Therapeutics | 7 |
| Kairos Pharma | 4 |
PMCB News
- 7 months ago - PharmaCyte sells Femasys stake, sees cash position rising to $20M - TheFly
- 7 months ago - PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Business Wire
- 10 months ago - PharmaCyte Biotech increases stake in TNF Pharmaceuticals by $3M - TheFly
- 10 months ago - PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications - Business Wire
- 11 months ago - PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing - Business Wire
- 11 months ago - PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Business Wire
- 2 years ago - MyMD Pharmaceuticals secures $7M investment from PharmaCyte Biotech - TheFly
- 2 years ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire